Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(24S)-24-hydroxycholesterol + [reduced NADPH-hemoprotein reductase] + O2
24,25-dihydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
(24S)-24-hydroxycholesterol + [reduced NADPH-hemoprotein reductase] + O2
24,27-dihydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
(24S)-hydroxycholesterol + [reduced NADPH-hemoprotein reductase] + O2
24,25-dihydroxycholesterol + 24,27-dihydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
preferred substrate in vitro
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
cholesterol 3-sulfate + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol 3-sulfate + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
dextromethorphan + [reduced NADPH-hemoprotein reductase] + O2
?
-
O- and N-demethylation
-
-
?
diclofenac + [reduced NADPH-hemoprotein reductase] + O2
?
-
4'-hydroxylation
-
-
?
phenacetin + [reduced NADPH-hemoprotein reductase] + O2
?
-
O-deethylation
-
-
?
additional information
?
-
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
-
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is responsible for cholesterol elimination from brain, (24S)-hydroxycholesterol can cross the blood-brain barrier, enter the circulation, and then be delivered to the liver for further degradation, cholesterol metabolism, overview, CYP46A1 may participate in metabolism of neurosteroids and drugs that are targeted to the central nervous system
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
-
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, cholesterol dynamics in the fetal and neonatal brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
-
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
-
-
-
-
?
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
-
enzyme deficiency leads to a suppression of the mevalonate pathway and a defect in learning
-
-
?
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is important in cholesterol homeostasis in cerebral structures, CYP46A1 might be involved in retinal pathologies like age-related macular degeneration or glaucomas, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
r
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
24-hydroxylation represents an important pathway by which cholesterol is secreted from the brain. The enzyme contributes little to overall bile acid synthesis but is important in the turnover of cholesterol in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
initiates cholesterol degradation in the brain. In addition to the involvement in cholesterol homeostasis in the brain, this enzyme may participate in metabolism of neurosteroids and drugs that can cross the blood-brain barrier and are targeted to the central nervous system
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
a major pathway for excretion of excess cholesterol from the brain, polymorphisms within the CYP46A1 gene are associated with Alzheimers disease incidence. The ratio between 24S-OHC and 27-OHC is of importance for the generation of amyloid in the brain, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
cholesterol enters the enzyme through the membrane. In CYP46A1, the three putative membrane-interacting peptides in the soluble domain, 59V-K69, 77V-K94, and 217L-K231, form the entrance to the substrate access channel and represent the secondary structural elements (the A helix and beta1 sheet and F-G loop regions)
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
24-hydroxylation represents an important pathway by which cholesterol is secreted from the brain. The enzyme contributes little to overall bile acid synthesis but is important in the turnover of cholesterol in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
cholesterol 24-hydroxylase constitutes a major tissue-specific pathway for cholesterol turnover in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is required for learning and memory formation, mice deficient in CYP46A1 exhibit impaired learning and defective hippocampal long-term potentiation, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
24-hydroxycholesterol induces, through the liver X receptor, activation of genes involved in cholesterol efflux, including the ATP-binding cassette transporter A1 and apolipoprotein E, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is important in cholesterol homeostasis in cerebral structures, CYP46A1 might be involved in retinal pathologies like age-related macular degeneration or glaucomas, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
additional information
?
-
-
CYP46A1 affects the pathophysiology of Alzheimers' disease and provides insight into how polymorphisms in the CYP46A1 gene might influence the pathophysiology of this prevalent disease
-
-
?
additional information
?
-
-
regulation of cholesterol synthesis is more important for maintenance of cholesterol homeostasis in brain than is the corresponding regulation of cholesterol removal
-
-
?
additional information
?
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
the enzyme is able to carry out side chain hydroxylations of two endogenous C27-steroids with and without a double bond between C5-C6 (7R-hydroxycholesterol and cholestanol, respectively) and introduce a hydroxyl group on the steroid nucleus of the C21-steroid hormones with the C4-C5 double bond (progesterone and testosterone). P450 46A1 metabolizes xenobiotics carrying out dextromethorphan O-demethylation and N-demethylations, diclofenac 4'-hydroxylation, and phenacetin O-deethylation
-
-
?
additional information
?
-
-
(24S)-hydroxycholesterol is a potent activator of the LXR receptor, CYP46A1-deficiency plays a role in the pathogenesis of this neurological disorder, such as Alzheimer's disease
-
-
?
additional information
?
-
-
cholesterol metabolism is important in Alzheimer's disease pathogenesis, the enzyme is a risk factor for Alzheimer's disease, along with cholesterol 25-hydroxylase and ATP-binding cassette transporter A1, overview
-
-
?
additional information
?
-
-
CYP46A1 shows broad substrate specificity
-
-
?
additional information
?
-
-
(24S)-24-hydroxycholesterol activates alpha- and beta-secretases, while (27S)-27-hydroxycholesterol inhibits them, overview
-
-
?
additional information
?
-
active site structure and substrate binding, overview
-
-
?
additional information
?
-
coupled assay with recombinant Rattus norvegicus NADPH cytochrome P450 oxidoreductase
-
-
?
additional information
?
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
additional information
?
-
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is responsible for cholesterol elimination from brain, (24S)-hydroxycholesterol can cross the blood-brain barrier, enter the circulation, and then be delivered to the liver for further degradation, cholesterol metabolism, overview, CYP46A1 may participate in metabolism of neurosteroids and drugs that are targeted to the central nervous system
-
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, cholesterol dynamics in the fetal and neonatal brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + NADPH + O2
(24S)-hydroxycholesterol + NADP+ + H2O
-
the enzyme is important in cholesterol metabolism in the brain, overview
the product is able to travers the blood-brain barrier, while the substrate is not, transport, and excretion of (24S)-hydroxycholesterol, oxycholesterol transport mechanisms, overview
-
?
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
-
enzyme deficiency leads to a suppression of the mevalonate pathway and a defect in learning
-
-
?
cholesterol + reduced adrenodoxin + O2
24-hydroxycholesterol + oxidized adrenodoxin + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is important in cholesterol homeostasis in cerebral structures, CYP46A1 might be involved in retinal pathologies like age-related macular degeneration or glaucomas, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
r
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
24-hydroxylation represents an important pathway by which cholesterol is secreted from the brain. The enzyme contributes little to overall bile acid synthesis but is important in the turnover of cholesterol in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
initiates cholesterol degradation in the brain. In addition to the involvement in cholesterol homeostasis in the brain, this enzyme may participate in metabolism of neurosteroids and drugs that can cross the blood-brain barrier and are targeted to the central nervous system
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
a major pathway for excretion of excess cholesterol from the brain, polymorphisms within the CYP46A1 gene are associated with Alzheimers disease incidence. The ratio between 24S-OHC and 27-OHC is of importance for the generation of amyloid in the brain, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
24-hydroxylation represents an important pathway by which cholesterol is secreted from the brain. The enzyme contributes little to overall bile acid synthesis but is important in the turnover of cholesterol in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
cholesterol 24-hydroxylase constitutes a major tissue-specific pathway for cholesterol turnover in the brain
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is required for learning and memory formation, mice deficient in CYP46A1 exhibit impaired learning and defective hippocampal long-term potentiation, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
24-hydroxycholesterol induces, through the liver X receptor, activation of genes involved in cholesterol efflux, including the ATP-binding cassette transporter A1 and apolipoprotein E, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + H+ + O2
(24S)-24-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O
-
the enzyme is important in cholesterol homeostasis in cerebral structures, CYP46A1 might be involved in retinal pathologies like age-related macular degeneration or glaucomas, overview
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
cholesterol + [reduced NADPH-hemoprotein reductase] + O2
(24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein reductase] + H2O
-
-
-
?
additional information
?
-
-
CYP46A1 affects the pathophysiology of Alzheimers' disease and provides insight into how polymorphisms in the CYP46A1 gene might influence the pathophysiology of this prevalent disease
-
-
?
additional information
?
-
-
regulation of cholesterol synthesis is more important for maintenance of cholesterol homeostasis in brain than is the corresponding regulation of cholesterol removal
-
-
?
additional information
?
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
(24S)-hydroxycholesterol is a potent activator of the LXR receptor, CYP46A1-deficiency plays a role in the pathogenesis of this neurological disorder, such as Alzheimer's disease
-
-
?
additional information
?
-
-
cholesterol metabolism is important in Alzheimer's disease pathogenesis, the enzyme is a risk factor for Alzheimer's disease, along with cholesterol 25-hydroxylase and ATP-binding cassette transporter A1, overview
-
-
?
additional information
?
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
additional information
?
-
-
the enzyme is a mediator of cholesterol homeostasis in the brain
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction
-
disruption of the cholesterol 24-hydroxylase gene causes an 50% decrease in cholesterol turnover, which is compensated for by an equal decrease in the rate of de novo cholesterol synthesis. Mice lacking cholesterol 24-hydroxylase show that whole-body fatty acid and cholesterol metabolism are normal. Profound learning disabilities in cholesterol 24-hydroxylase-deficient mice are often caused by gross anatomical defects in the subregions of the brain implicated in the behavior. A minimal concentration of 0.2 mM geranylgeraniol is required to restore LTP in hippocampal slices from knockout mice
malfunction
-
a single nucleotide polymorphism the in CYP46A1 gene, designated as rs754203, is a risk factor for glaucoma. The enzyme participates to retinal ganglion cell loss under pathophysiological conditions
malfunction
CYP46A1 expression levels are reduced in Huntington's disease. CYP46A1 protein levels are decreased in the putamen, but not cerebral cortex samples, of post-mortem Huntington's disease patients when compared to controls. Huntington's disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin leading to degeneration of striatal neurons. Altered brain cholesterol homeostasis is implicated in Huntington's disease, with increased accumulation of cholesterol in striatal neurons yet reduced levels of cholesterol metabolic precursors
malfunction
knocking down CYP46A1 expression in the striatum, via an adeno-associated virus-mediated delivery of selective shCYP46A1, reproduced the Huntingtons disease phenotype, with spontaneous striatal neuron degeneration and motor deficits. CYP46A1 expression levels are reduced in Huntington's disease. In the R6/2 Huntington's disease mouse model, adeno-associated virus-mediated delivery of CYP46A1 into the striatum decreases neuronal atrophy, decreases the number, intensity level and size of expansion in huntingtin aggregates and improves motor deficits, as assessed by rotarod and clasping behavioural tests. Adeno-associated virus-CYP46A1 infection in R6/2 mice also restores levels of cholesterol and lanosterol and increases levels of desmosterol
malfunction
polymorphisms in the CYP46 gene and CYP46A1 enzyme dysfunction are involved in neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. The 24(S)-hydroxycholesterol levels in cerebrospinal fluid are higher in patients with Alzheimer's disease compared to healthy control. CYP46A1 inhibition by voriconazole decreases 24S-hydroxycholesterol levels in the retina and affects cholesterol homeostasis and function in the retina
malfunction
-
knocking down CYP46A1 expression in the striatum, via an adeno-associated virus-mediated delivery of selective shCYP46A1, reproduced the Huntingtons disease phenotype, with spontaneous striatal neuron degeneration and motor deficits. CYP46A1 expression levels are reduced in Huntington's disease. In the R6/2 Huntington's disease mouse model, adeno-associated virus-mediated delivery of CYP46A1 into the striatum decreases neuronal atrophy, decreases the number, intensity level and size of expansion in huntingtin aggregates and improves motor deficits, as assessed by rotarod and clasping behavioural tests. Adeno-associated virus-CYP46A1 infection in R6/2 mice also restores levels of cholesterol and lanosterol and increases levels of desmosterol
-
metabolism
-
CYP46A1 gene variations (rs7157609 and rs4900442) influence the risk factor for Alzheimer's disease via an influence on brain cholesterol metabolism, especially the interaction term of both SNPs and the resulting haplotype reveal a strong association with the risk of Alzheimers disease
metabolism
-
cholesterol 24S-hydroxylase is a cholesterol metabolic enzyme with regulatory function in traumatic brain injury, overview
physiological function
-
amyloid precursor protein expression and amyloid plaque deposition in the cortex and hippocampus of male and female Alzheimer's disease mice between the ages of 3 to 15 months are similar in the presence and absence of cholesterol 24-hydroxylase. Loss of one or both cholesterol 24-hydroxylase alleles increases longevity in Alzheimers disease mice. Cholesterol synthetic rates are reduced in animals lacking 24-hydroxylase, and this reduction is specific to cholesterol
physiological function
-
cholesterol 24-hydroxylase regulates TrkB activity in mature hippocampal neurons
physiological function
-
cholesterol 24-hydroxylase regulates TrkB activity in mature hippocampal neurons
physiological function
-
CYP46A1 gene may act to modulate the course of cognitive deterioration in late life. IVS2-150 polymorphism is associated with a higher risk of cognitive deterioration in Chinese older persons. IVS3-128 CC genotype is higher in improved or stable group, suggesting a protective role. Ppolymorphisms IVS1-192 and IVS4-122 do not show any significant association with cognitive function
physiological function
-
overexpression of human CYP46A1 gene does not modify the expression of endogenous murine Cyp46A1 gene
physiological function
-
polymorphisms in the human gene are linked to neurodegenerative disorders, such as Alzheimer's disease
physiological function
recombinant CYP46A1 is catalytically active when associated with Escherichia coli membranes
physiological function
-
selective overexpression of CYP46A1 in neurons can reduce Abeta peptides and amyloid deposits in mouse models of Alzheimer's disease when the overexpression of CYP46A1 is induced before or after the formation of amyloid plaques. Injection of adeno-associated vector encoding CYP46A1 in the cortex and hippocampus of APP23 mice before the onset of amyloid deposits markedly reduces Abeta peptides, amyloid deposits and trimeric oligomers at 12 months of age. Neuronal overexpression of CYP46A1 decreases microgliosis and astrocytosis and improves cognitive deficits in APP23 mice. AAV5-wtCYP46A1 vector injection in the cortex and hippocampus of amyloid precursor protein/presenilin 1 mice after the onset of amyloid deposits also reduces markedly the number of amyloid plaques in the hippocampus, and to a less extent in the cortex, 3 months after the injection
physiological function
-
the capacity to turn over cholesterol via the cholesterol 24-hydroxylase pathway may be acquired early during development of the central nervous system. The enzyme reduces the excretion of sterols from the brain but does not abolish this removal process
physiological function
-
the rs754203 SNP in CYP46A1 is associated with a risk for primary open angle glaucoma. Frequency of the TT-genotype and T-allele in the CYP46A1 intron 2 rs754203 polymorphism is significantly higher in the population of primary open angle glaucom patients compared to control group
physiological function
-
visual disturbances in CYP46A1 gene knockout mice
physiological function
-
24S-hydroxycholesterol and LXR agonist TO-901317 both increase SREBP-1 mRNA levels while 24S-hydroxycholesterol decreases SREBP-2 mRNA levels, real-time PCR quantification, overview
physiological function
-
CYP46A1 overexpression enhances spatial memory retention in aged female mice
physiological function
cholesterol 24-hydroxylase controls cholesterol elimination from the brain
physiological function
cholesterol 24-hydroxylase is the neuronal-specific and rate-limiting enzyme for cholesterol conversion to 24S-hydroxycholesterol, regulation of cholesterol homeostasis by CYP46A1
physiological function
cholesterol 24-hydroxylase is the neuronal-specific and rate-limiting enzyme for cholesterol conversion to 24S-hydroxycholesterol, regulation of cholesterol homeostasis by CYP46A1. In vitro, CYP46A1 restoration protects SThdhQ111 and Exp-HTT-expressing striatal neurons in culture from cell death
physiological function
cholesterol 24S-hydroxylase converts cholesterol into 24S-hydroxycholesterol in neurons and participates in cholesterol homeostasis in the central nervous system, including the retina
physiological function
mechanism of CYP46A1 allostery and the pathway for the signal transmission from the P450 allosteric site to the active site, overview
physiological function
-
overexpression of human CYP46A1 gene does not modify the expression of endogenous murine Cyp46A1 gene
-
physiological function
-
cholesterol 24-hydroxylase is the neuronal-specific and rate-limiting enzyme for cholesterol conversion to 24S-hydroxycholesterol, regulation of cholesterol homeostasis by CYP46A1. In vitro, CYP46A1 restoration protects SThdhQ111 and Exp-HTT-expressing striatal neurons in culture from cell death
-
physiological function
-
cholesterol 24S-hydroxylase converts cholesterol into 24S-hydroxycholesterol in neurons and participates in cholesterol homeostasis in the central nervous system, including the retina
-
additional information
-
Cyp46 is upregulated in traumatic brain injury. Membrane damage during traumatic brain injury alters the brain homeostasis of cholesterol and other lipids. Reaction product 24S-hydroxycholesterol decreases mRNA levels of the cholesterol synthesis genes HMG CoA reductase, squalene synthase, and FPP synthase but does not alter levels of the mRNA of fatty acid synthesis genes acetyl CoA carboxylase or fatty acid synthase
additional information
-
increased expression of cholesterol 24S-hydroxylase in brain results in disruption of glial glutamate transporter EAAT2 association with lipid rafts with a potential role in Alzheimers disease, overview
additional information
mapping of the binding region for CYP46A1 redox partner oxidoreductase and identification of allosteric and redox partner binding sites which share a common border, by using a combination of hydrogen-deuterium exchange coupled to mass spectrometry, computational modeling, site-directed mutagenesis, and analysis of the CYP46A1 crystal structure, overview. Residues K422 and R424 are important for enzyme activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Mast, N.; Andersson, U.; Nakayama, K.; Bjorkhem, I.; Pikuleva, I.A.
Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications
Arch. Biochem. Biophys.
428
99-108
2004
Homo sapiens
brenda
Mast, N.; Norcross, R.; Andersson, U.; Shou, M.; Nakayama, K.; Bjorkhem, I.; Pikuleva, I.A.
Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain
Biochemistry
42
14284-14292
2003
Homo sapiens
brenda
Russell, D.W.
Oxysterol biosynthetic enzymes
Biochim. Biophys. Acta
1529
126-135
2000
Mus musculus (Q9WVK8), Homo sapiens (Q9Y6A2)
brenda
Lund, E.G.; Xie, C.; Kotti, T.; Turley, S.D.; Dietschy, J.M.; Russell, D.W.
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
J. Biol. Chem.
278
22980-22988
2003
Mus musculus
brenda
Brown, J.3rd.; Theisler, C.; Silberman, S.; Magnuson, D.; Gottardi-Littell, N.; Lee, J.M.; Yager, D.; Crowley, J.; Sambamurti, K.; Rahman, M.M.; Reiss, A.B.; Eckman, C.B.; Wolozin, B.
Differential expression of cholesterol hydroxylases in Alzheimer's disease
J. Biol. Chem.
279
34674-34681
2004
Homo sapiens
brenda
Ohyama, Y.; Meaney, S.; Heverin, M.; Ekstrom, L.; Brafman, A.; Shafir, M.; Andersson, U.; Olin, M.; Eggertsen, G.; Diczfalusy, U.; Feinstein, E.; Bjorkhem, I.
Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): Marked insensitivity towards different regulatory axes
J. Biol. Chem.
281
3810-3820
2006
Homo sapiens
brenda
Bogdanovic, N.; Bretillon, L.; Lund, E.G.; Diczfalusy, U.; Lannfelt, L.; Winblad, B.; Russell, D.W.; Bjorkhem, I.
On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells
Neurosci. Lett.
314
45-48
2001
Homo sapiens
brenda
Shibata, N.; Kawarai, T.; Lee, J.H.; Lee, H.S.; Shibata, E.; Sato, C.; Liang, Y.; Duara, R.; Mayeux, R.P.; St George-Hyslop, P.H.; Rogaeva, E.
Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease
Neurosci. Lett.
391
142-146
2006
Homo sapiens
brenda
Lund, E.G.; Guileyardo, J.M.; Russell, D.W.
cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain
Proc. Natl. Acad. Sci. USA
96
7238-7243
1999
Mus musculus (Q9WVK8), Mus musculus, Homo sapiens (Q9Y6A2), Homo sapiens
brenda
Luetjohann, D.
Cholesterol metabolism in the brain: importance of 24S-hydroxylation
Acta Neurol. Scand.
114 (Suppl. 185)
33-42
2006
Homo sapiens, Mus musculus, Sus scrofa
brenda
Pikuleva, I.A.
Cholesterol-metabolizing cytochromes P450
Drug Metab. Dispos.
34
513-520
2006
Homo sapiens
brenda
He, X.; Jenner, A.M.; Ong, W.Y.; Farooqui, A.A.; Patel, S.C.
Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury
J. Neuropathol. Exp. Neurol.
65
652-663
2006
Rattus norvegicus
brenda
Kotti, T.J.; Ramirez, D.M.; Pfeiffer, B.E.; Huber, K.M.; Russell, D.W.
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
Proc. Natl. Acad. Sci. USA
103
3869-3874
2006
Mus musculus
brenda
Famer, D.; Meaney, S.; Mousavi, M.; Nordberg, A.; Bjoerkhem, I.; Crisby, M.
Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway
Biochem. Biophys. Res. Commun.
359
46-50
2007
Homo sapiens
brenda
Bretillon, L.; Diczfalusy, U.; Bjoerkhem, I.; Maire, M.A.; Martine, L.; Joffre, C.; Acar, N.; Bron, A.; Creuzot-Garcher, C.
Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina
Curr. Eye Res.
32
361-366
2007
Bos taurus, Rattus norvegicus
brenda
Ramirez, D.M.; Andersson, S.; Russell, D.W.
Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain
J. Comp. Neurol.
507
1676-1693
2008
Mus musculus
brenda
Cartagena, C.M.; Ahmed, F.; Burns, M.P.; Pajoohesh-Ganji, A.; Pak, D.T.; Faden, A.I.; Rebeck, G.W.
Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain
J. Neurotrauma
25
1087-1098
2008
Rattus norvegicus
brenda
Mast, N.; White, M.A.; Bjorkhem, I.; Johnson, E.F.; Stout, C.D.; Pikuleva, I.A.
Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain
Proc. Natl. Acad. Sci. USA
105
9546-9551
2008
Homo sapiens (Q9Y6A2)
brenda
Mast, N.; Liao, W.L.; Pikuleva, I.A.; Turko, I.V.
Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase
Arch. Biochem. Biophys.
483
81-89
2009
Homo sapiens (Q9Y6A2), Homo sapiens
brenda
Fu, B.Y.; Ma, S.L.; Tang, N.L.; Tam, C.W.; Lui, V.W.; Chiu, H.F.; Lam, L.C.
Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study
Int. J. Geriatr. Psychiatry
24
921-926
2009
Homo sapiens
brenda
Russell, D.W.; Halford, R.W.; Ramirez, D.M.; Shah, R.; Kotti, T.
Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain
Annu. Rev. Biochem.
78
1017-1040
2009
Bos taurus, Canis lupus familiaris, Cavia porcellus, Gallus gallus, Oryctolagus cuniculus, Equus caballus, Equus sp., Homo sapiens, Macaca mulatta, Mus musculus, Ornithorhynchus anatinus, Pan troglodytes, Rattus norvegicus, Danio rerio (A5WWJ0), Xenopus laevis (Q7SYY2)
brenda
Shafaati, M.; O'Driscoll, R.; Bjoerkhem, I.; Meaney, S.
Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors
Biochem. Biophys. Res. Commun.
378
689-694
2009
Homo sapiens, Mus musculus, Mus musculus C57B6-J
brenda
Koelsch, H.; Luetjohann, D.; Jessen, F.; Popp, J.; Hentschel, F.; Kelemen, P.; Schmitz, S.; Maier, W.; Heun, R.
CYP46A1 variants influence Alzheimers disease risk and brain cholesterol metabolism
Eur. Psychiatry
24
183-190
2009
Homo sapiens
brenda
Fourgeux, C.; Martine, L.; Bjoerkhem, I.; Diczfalusy, U.; Joffre, C.; Acar, N.; Creuzot-Garcher, C.; Bron, A.; Bretillon, L.
Primary open angle glaucoma: Association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and pPlasma 24-hydroxycholesterol levels
Invest. Ophthalmol. Vis. Sci.
50
5712-5717
2009
Homo sapiens
brenda
Shafaati, M.; Mast, N.; Beck, O.; Nayef, R.; Heo, G.Y.; Bjoerkhem-Bergman, L.; Lutjohann, D.; Bjoerkhem, I.; Pikuleva, I.A.
The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase (CYP46A1) in vitro and in vivo
J. Lipid Res.
51
318-323
2010
Homo sapiens, Mus musculus
brenda
Martin, M.G.; Perga, S.; Trovo, L.; Rasola, A.; Holm, P.; Rantamaeki, T.; Harkany, T.; Castren, E.; Chiara, F.; Dotti, C.G.
Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro
Mol. Biol. Cell
19
2101-2112
2008
Mus musculus, Rattus norvegicus
brenda
Hudry, E.; Van Dam, D.; Kulik, W.; De Deyn, P.P.; Stet, F.S.; Ahouansou, O.; Benraiss, A.; Delacourte, A.; Bougneres, P.; Aubourg, P.; Cartier, N.
Adeno-associated Virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimers disease
Mol. Ther.
18
44-53
2010
Homo sapiens, Mus musculus, Mus musculus APP23
brenda
Solomon, A.; Leoni, V.; Kivipelto, M.; Besga, A.; Oksengard, A.R.; Julin, P.; Svensson, L.; Wahlund, L.O.; Andreasen, N.; Winblad, B.; Soininen, H.; Bjoerkhem, I.
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimers disease
Neurosci. Lett.
462
89-93
2009
Homo sapiens
brenda
Halford, R.W.; Russell, D.W.
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimers disease, but does extend lifespan
Proc. Natl. Acad. Sci. USA
106
3502-3506
2009
Mus musculus
brenda
Cartagena, C.M.; Burns, M.P.; Rebeck, G.W.
24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury
Brain Res.
1319
1-12
2010
Homo sapiens
brenda
Smiljanic, K.; Lavrnja, I.; Mladenovic Djordjevic, A.; Ruzdijic, S.; Stojiljkovic, M.; Pekovic, S.; Kanazir, S.
Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner
Histochem. Cell Biol.
134
159-169
2010
Rattus norvegicus, Rattus norvegicus Wistar
brenda
Tian, G.; Kong, Q.; Lai, L.; Ray-Chaudhury, A.; Lin, C.L.
Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimers disease
J. Neurochem.
113
978-989
2010
Homo sapiens
brenda
Liao, W.L.; Heo, G.Y.; Dodder, N.G.; Reem, R.E.; Mast, N.; Huang, S.; Dipatre, P.L.; Turko, I.V.; Pikuleva, I.A.
Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain
J. Proteome Res.
10
241-248
2011
Homo sapiens, Homo sapiens (Q9Y6A2)
brenda
Fourgeux, C.; Bron, A.; Acar, N.; Creuzot-Garcher, C.; Bretillon, L.
24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma
Chem. Phys. Lipids
164
496-499
2011
Homo sapiens
brenda
Maioli, S.; Bavner, A.; Ali, Z.; Heverin, M.; Ismail, M.A.; Puerta, E.; Olin, M.; Saeed, A.; Shafaati, M.; Parini, P.; Cedazo-Minguez, A.; Bjoerkhem, I.
Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?
PLoS ONE
8
e68534
2013
Homo sapiens
brenda
Fourgeux, C.; Martine, L.; Acar, N.; Bron, A.M.; Creuzot-Garcher, C.P.; Bretillon, L.
In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina
Biochem. Biophys. Res. Commun.
446
775-781
2014
Rattus norvegicus (F7EN52), Rattus norvegicus Wistar (F7EN52)
brenda
Boussicault, L.; Alves, S.; Lamaziere, A.; Planques, A.; Heck, N.; Moumne, L.; Despres, G.; Bolte, S.; Hu, A.; Pages, C.; Galvan, L.; Piguet, F.; Aubourg, P.; Cartier, N.; Caboche, J.; Betuing, S.
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntingtons disease
Brain
139
953-970
2016
Homo sapiens (Q9Y6A2), Homo sapiens, Mus musculus (Q9WVK8), Mus musculus, Mus musculus C57BL/6 (Q9WVK8)
brenda
Uto, Y.
Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676)
Expert Opin. Ther. Pat.
25
373-377
2015
Homo sapiens (Q9Y6A2)
brenda
Anderson, K.W.; Mast, N.; Hudgens, J.W.; Lin, J.B.; Turko, I.V.; Pikuleva, I.A.
Cholesterol hydroxylase CYP46A1: mapping of the allosteric site for efavirenz, a drug that stimulates enzyme activity
J. Biol. Chem.
291
11876-81186
2016
Homo sapiens (Q9Y6A2)
brenda